LOCUS AK308068 1002 bp mRNA linear HTC 12-JAN-2008
DEFINITION Homo sapiens cDNA, FLJ98016.
ACCESSION AK308068
VERSION AK308068.1
KEYWORDS HTC; HTC_FLI; oligo capping.
SOURCE Homo sapiens (human)
ORGANISM Homo sapiens
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
REFERENCE 1 (bases 1 to 1002)
AUTHORS Isogai,T. and Yamamoto,J.
TITLE Direct Submission
JOURNAL Submitted (11-JAN-2008) to the DDBJ/EMBL/GenBank databases.
Contact:Takao Isogai
Reverse Proteomics Research Institute; 1-9-11 Kaji-cho,
Chiyoda-ku, Tokyo 101-0044, Japan
E-mail :flj-cdna@nifty.com
REFERENCE 2
AUTHORS Wakamatsu,A., Yamamoto,J., Kimura,K., Ishii,S., Watanabe,K.,
Sugiyama,A., Murakawa,K., Kaida,T., Tsuchiya,K., Fukuzumi,Y.,
Kumagai,A., Oishi,Y., Yamamoto,S., Ono,Y., Komori,Y., Yamazaki,M.,
Kisu,Y., Nishikawa,T., Sugano,S., Nomura,N. and Isogai,T.
TITLE NEDO human cDNA sequencing project
JOURNAL Unpublished (2008)
COMMENT Human cDNA sequencing project focused on splicing variants of mRNA
in NEDO functional analysis of protein and research application
project supported by Ministry of Economy, Trade and Industry,
Japan; cDNA selection for complete cds sequencing: Reverse
Proteomics Research Institute (REPRORI), Hitachi, Ltd., Japan
(Hitachi) and Japan Biological Informatics Consortium, Japan
(JBIC); cDNA complete cds sequencing: JBIC; cDNA library
construction: Helix Research Institute supported by Japan Key
Technology Center, Japan (HRI); cDNA 5'- & 3'-end sequencing:
Research Association for Biotechnology, Japan, Biotechnology
Center, National Institute of Technology and Evaluation, Japan and
HRI; cDNA mapping to human genome: Central Research Laboratory,
Hitachi; evaluation and annotation: REPRORI.
FEATURES Location/Qualifiers
source 1..1002
/cell_line="NT2"
/cell_type="teratocarcinoma"
/clone="NT2RI2012396"
/clone_lib="NT2RI2"
/db_xref="H-InvDB:HIT000426934"
/db_xref="taxon:9606"
/mol_type="mRNA"
/note="cloning vector: pME18SFL3"
/note="mRNA from NT2 neuronal precursor cells treated
2-weeks mitotic inhibitor after 5-weeks retinoic acid
(RA) induction."
/note="majorly NT2 neuron"
/organism="Homo sapiens"
BASE COUNT 320 a 203 c 228 g 251 t
ORIGIN
1 gtccccgcgg ctctgtgtcc cctgctagcc gtaggccgtg tgacccgcag gcaccgggag
61 atccagaagt gaaacgccag gctctctgga ggccaggaga tggtgtgatt tgtccagaga
121 atctttccta agaggaaatc ccagagaagc aggagaaaga gaaagaaatg gctggtgctc
181 agactctgtt gacgttcagg gatgtggcca tagaattctc cctggaggag tggaaatgcc
241 tggacctcgc tcagcagaat ttgtacaggg atgtgatgtt ggagaactac agaaacttgt
301 tctccgttgg tctcactgtc tgtaagccag gcctgatcac ctgcctggag caacgaaaag
361 agccctggaa tgtgaagaga caggaggcag cagacggaca tccagcactg tgctcacctg
421 gggtgctgca aactgtgaaa tggtttttag agttcagatg catcttctca ctagctatgt
481 cttctcattt tacccaagac cttctgccag agcagggcat acaagatgca ttcccaaaaa
541 gaatactgag aggatatgga aattgtggcc ttgataattt atatttaagg aaagactggg
601 aaagtttaga tgagtgtaag ttgcaaaaag attataatgg acttaaccaa tgttcatcaa
661 ctacccatag caaaatcttt caatataata aatatgttaa aatctttgat aacttttcaa
721 atttacatag acgtaatata agtaatactg gagagaaacc tttcaaatgt caagaatgtg
781 gcaaatcctt tcaaatgctc tcattcctaa ctgaacatca gaaaattcac actggaaaaa
841 aaattccaaa aatgtggaga atgtggcaaa acctttatcc agtgctcaca ctttactgaa
901 cctgagaaca ttgacactgg agagaaacct tacaagtgtc aagaatgtaa caacgtcatt
961 aaaacttgct cagtccttac taaaaataga atttatgccg ga
//